PhotoniCare Announces a First Close of $4.6 Million in Series B Financing, a Manufacturing Partnership with Gentex Corporation, and Relocation of its Headquarters to Grand Rapids, Michigan
GRAND RAPIDS, Mich., Dec. 03, 2024 (GLOBE NEWSWIRE) — PhotoniCare Inc., a medical device company dedicated to delivering innovation to frontline care that demonstrably enhances patient outcomes, is pleased to announce that it has secured $4.6 million in Series B financing, formed a manufacturing partnership with Gentex Corporation for its first-in-class, FDA-cleared OtoSight™ Middle Ear Scope, and finalized the relocation of its headquarters from Champaign, Illinois to Grand Rapids, Michigan. The new money is the first close in an expected $9 million round.
